Rulemaking Information

**ATTENTION LICENSEES**

New rules for ALL licensees 

(Pharmacists, Interns/Preceptors, Certified Oregon Pharmacy Technicians and Pharmacy Technicians) 

became effective on 3/1/2024. 

To navigate the new Oregon Administrative Rules (OARs), review the OBOP Navigation Chart. 

December 17, 2024 Temporary Rule Noticed

• Div 115 - Pharmacists - Services: Prescribing - Protocol Compendium *Effective 12/17/2024
  
• Contraception (v. 12/2024)
  
• Coronavirus 19 (v. 12/17/2024) 
  
• Hepatitis B containing vaccines (v. 12/2024) 
  
• Meningococcal containing vaccines (v. 12/2024)
  
• Pneumococcal (v. 12/2024) 
  
• Respiratory Syncytial Virus (v. 12/17/2024) 
  
• Vulvovaginal Candidiasis (VVC) *REPEAL 
  

December 2024

The board permanently adopted the following rules at the December 2024 Board Meeting: 

• Div 035 - Operation of Nonprescription and Medical Device, Equipment and Gas Outlets - Registration Requirements *Effective 12/17/2024
  
• Div 115 - Pharmacists - Services: Prescribing - Protocol Compendium *Effective 12/17/2024
  
• Coronavirus 19 (v. 12/2024)
• Influenza Inactivated Influenza Vaccines and Recombinant Influenza Vaccines 2024-2025 ( v. 12/2024)
• Influenza Live Attenuated Influenza Vaccine 2024-2025 (v. 12/2024)
• Respiratory Syncytial Virus (v. 12/2024) 
  

November 26, 2024 Rulemaking Hearing

• Div 035 - Operation of Nonprescription and Medical Device, Equipment and Gas Outlets - Registration Requirements
  
• Div 115 - Pharmacists - Services: Prescribing - Protocol Compendium 
  
• Coronavirus 19 (v. 12/2024)
• Influenza Inactivated Influenza Vaccines and Recombinant Influenza Vaccines 2024-2025 (v. 12/2024)
• Influenza Live Attenuated Influenza Vaccine 2024-2025 (v. 12/2024)
• Respiratory Syncytial Virus (v. 12/2024)

October 11, 2024 Temporary Rule Noticed

• OAR 855-035-0005 - Operation of Nonprescription and Medical Device, Equipment and Gas Outlets - Registration Requirements *Effective 10/11/2024 
  

August 9, 2024 Temporary Rule Noticed

• OAR 855-115-0345 Pharmacists - Services: Prescribing - Protocol Compendium *Effective 8/9/2024
  
• Coronavirus 19 (v. 08/2024) 
  
• Influenza Inactivated Influenza Vaccines and Recombinant Influenza Vaccines 2024-2025 (v. 08/2024)
  
• Influenza Live Attenuated Influenza Vaccine 2024-2025 (v. 08/2024)
  
• Respiratory Syncytial Virus (v. 08/2024)
  

August 2024

The board permanently adopted the following rules at the August 2024 Board Meeting:

• Div 115 - Pharmacists - Services: Prescribing - Protocol Compendium *Effective 8/9/2024
  
• Continuation of Therapy including Emergency refills of insulin and early refills of opioid use disorder medications (v. 08/2024)
  
• SARS-CoV-2 Antiviral (v. 08/2024)
  
• Div 135 - Continuing Pharmacy Education - Definitions & General Requirements *Effective 8/9/2024
  
• Div 139 - Remote Dispensing Site Pharmacy - Outlet: General Requirements *Effective 8/9/2024
  

July 23, 2024 Rulemaking Hearing

• Div 115 - Pharmacists - Services: Prescribing - Protocol Compendium
  
• Continuation of Therapy including Emergency refills of insulin and early refills of opioid use disorder medications (v. 08/2024)
• SARS-CoV-2 Antiviral (v. 08/2024)
  
• 2024 HB 4002
  
• 2024 SB 1506
  
• Coronavirus 2019 (v.08/2024) 
  
• Div 135 - Continuing Pharmacy Education - Definitions & General Requirements - Veterinary 
  
• Div 139 - Remote Dispensing Site Pharmacy - Outlet: General Requirements - Mileage 
  
• REVISED NOTICE - Div 139 - Remote Dispensing Site Pharmacy - Outlet: General Requirements - Mileage 
  

June 2024

The board permanently adopted the following rules at the June 2024 Board Meeting:

• Div 115 - Pharmacists - PIC Qualifications & Limitations *REPEAL *Effective 6/20/2024
  
• Div 115 - Pharmacists - Services: Prescribing - Formulary & Protocol Compendium *Effective 6/20/2024
  
• Formulary Devices and Supplies
  
• Continuation of Therapy including Emergency Refills of Insulin
  
• Pseudoephedrine (v. 06/2021) *REPEAL *Effective 6/20/2024 
  
• Tobacco Cessation 
  
• Travel Medications 
  
• Sexually Transmitted Infections Post-exposure Prophylaxis (STI PEP) 
  
• Short-acting Opioid Antagonists 
  
• Standard Protocol for All Vaccines: Cover Page & Assessment and Treatment Care Pathway 
  
• Standard Protocol for All Vaccines: Managing Adverse Reactions 
  
• Coronavirus 19 
  
• Haemophilus Influenzae type b  
  
• Influenza Inactivated Influenza Vaccines and Recombinant Influenza Vaccines 2023-2024 
  
• Japanese Encephalitis 
  
• Meningococcal containing vaccines 
  
• Pneumococcal 
  
• Polio 
  
• Respiratory Syncytial Virus 
  
• Tetanus, Diphtheria containing vaccines
  
• Yellow Fever 
  
  
  
• Div 115 - Pharmacists – Services: Prescribing Practices – Short-acting Opioid Antagonists *Effective 6/20/2024
  
• Div 120 - Interns & Preceptors – Prohibited Practices *Effective 6/20/2024
  
• Div 020 - Pharmacist Prescriptive Authority – Protocol Compendium *REPEAL *Effective 6/20/2024
  
• Div 006/041/043/045/080/115/120/135/139/141 - Standards Adopted by Reference *Effective 6/20/2024
  
• Div 115 - Pharmacists - Responsibilities: Outlet - Delegation of Final Verification *Effective 6/20/2024
  

May 22, 2024 Rulemaking Hearing

• Div 115 - Pharmacists - PIC Qualifications & Limitations *REPEAL 
  
• Div 115 - Pharmacists - Services: Prescribing - Formulary & Protocol Compendium 
  
• Formulary Devices and Supplies
  
• Continuation of Therapy (v. 06/2024)
  
• Pseudoephedrine (v. 06/2021) *REPEAL
  
• Tobacco Cessation (v. 06/2024)
  
• Travel Medications (v. 06/2024)
• Sexually Transmitted Infections Post-exposure Prophylaxis (STI PEP) (v. 06/2024)
• Short-acting Opioid Antagonists (v. 06/2024)
• Standard Protocol for All Vaccines: Cover Page & Assessment and Treatment Care Pathway (v. 06/2024)
• Standard Protocol for All Vaccines: Managing Adverse Reactions (v. 06/2024)
• Coronavirus 19 (v. 06/2024)
• Haemophilus Influenzae type b  (v. 06/2024)
• Influenza Inactivated Influenza Vaccines and Recombinant Influenza Vaccines 2023-2024 (v. 06/2024)
• Japanese Encephalitis (v. 06/2024)
• Meningococcal containing vaccines (v. 06/2024)
• Pneumococcal (v. 06/2024)
• Polio (v. 06/2024)
• Respiratory Syncytial Virus (v. 06/2024)
  
• Tetanus, Diphtheria containing vaccines (v. 06/2024)
• Yellow Fever (v. 06/2024)
  
• Div 115 – Pharmacists – Services: Prescribing Practices – Short-acting Opioid Antagonists 
  
• Div 120 – Interns & Preceptors – Prohibited Practices
  
• Div 020 – Pharmacist Prescriptive Authority – Protocol Compendium *REPEAL
  
• Div 006/041/043/045/080/115/120/135/139/141 – Standards Adopted by Reference
• Div 115 - Pharmacists - Responsibilities: Outlet - Delegation of Final Verification 
  
  

March 4, 2024 Temporary Rule Noticed

• OAR 855-115-0345 Pharmacist- Services: Prescribing - Protocol Compendium - Vaccines - Coronavirus 19  *Effective 3/4/2024 
• Coronavirus 19 
  

March 2024 Temporary Rule Noticed

• OAR 855-115-0345 Pharmacist- Services: Prescribing - Protocol Compendium - Vaccines *Effective 3/1/2024
  

March 2024

The board permanently repealed the following rules at the Special February 23, 2024 Board Meeting:

• OAR 855-019-0270, OAR 855-019-0280, OAR 855-019-0290 and OAR 855-025-0024 related to Pharmacist/COPT/PT Administration of Vaccines  *Effective 2/29/2024
  

The board permanently adopted the following rule at the February 2024 Board Meeting:

• OAR 855-115-0150 Pharmacist- Prohibited Practices *Effective 3/1/2024
  

February 2024 Temporary Rule Noticed 

• Division 020 related to Temporary Suspension of Pharmacist Prescriptive Authority - Protocol Compendium *Effective 2/29/2024
  

February 2024

The board permanently adopted the following rules at the February 2024 Board Meeting:

• Division 001 related to Procedural Rules - Repeal  *Effective 2/29/2024
  
• Division 006 related to Definitions  *Effective 3/1/2024
  
• Division 010 related to Board Administration & Policies - Repeal  *Effective 2/29/2024
  
• Division 019 related to Pharmacists - Repeal  *Effective 2/29/2024
  
• Division 020 related to Pharmacist Prescriptive Authority - Repeal  *Effective 2/29/2024
  
• Division 025 related to Pharmacy Technicians - Repeal  *Effective 2/29/2024
  
• Division 031 related to Interns - Repeal  *Effective 2/29/2024 
  
• Divisions 041/110 related to Consulting Drugless Pharmacies  *Effective 2/29/2024 
  
• Division 041 related to Institutional Drug Outlet Labeling Requirements for Short-acting Opioid Antagonists *Effective 2/15/2024
  
• Division 115 related to Pharmacists - Applicability  *Effective 3/1/2024
  
• Division 115 related to Pharmacists - Collaborative Drug Therapy Management (CDTM)  *Effective 3/1/2024
  
• Division 120 related to Preceptor License Renewal or Reinstatement  *Effective 3/1/2024
  

February 22, 2024 Rulemaking Hearing

• OAR 855-019-0270, OAR 855-019-0280, OAR 855-019-0290 and OAR 855-025-0024 related to Pharmacist/COPT/PT Administration of Vaccines *REPEAL
  

January 24, 2024 Rulemaking Hearing

• Division 001 related to Procedural Rules *REPEAL
  
• Division 006 related to Definitions 
  
• Division 010 related to Board Administration and Policies *REPEAL 
  
• Division 019 related to Pharmacists *REPEAL 
  
• Division 020 related to Pharmacist Prescriptive Authority *REPEAL 
  
• Division 025 related to Pharmacy Technicians *REPEAL 
  
• Division 031 related to Interns *REPEAL 
  
• Divisions 041/110 related to Consulting Drugless Pharmacies *Rule Amendments and REPEAL
  
• Division 041 related to Institutional Drug Outlet Labeling Requirements for Short-acting Opioid Antagonists
  
• Division 115 related to Pharmacists - Applicability
  
• Division 115 related to Pharmacists - Collaborative Drug Therapy Management (CDTM)
  
• Division 115 related to Pharmacists - Prohibited Practices
  
• Division 120 related to Preceptor License Renewal or Reinstatement 
  

2023 Proposed & Adopted Rules 

December 2023 Temporary Rule Noticed

• Division 041 related to Institutional Drug Outlet Labeling for Short-acting Opioid Antagonist  *Effective 1/1/2024 
  

December 2023

The board permanently adopted the following rules at the December 2023 Board Meeting:

• Divisions 019/025/041/139 related to Pharmacist/COPT/PT Administration of Vaccines *Effective 1/1/2024
  
• Division 020 related to Vaccination Protocols - Protocol Compendium *Effective 2/1/2024
  
• Standard Protocol for All Vaccines: Cover Page & Assessment and Treatment Care Pathway (v. 2/2024)
  
• Standard Protocol for All Vaccines: Managing Adverse Reactions (v. 2/2024)
  
• Cholera (v. 2/2024)
  
• Coronavirus 19 (v. 2/2024)
  
• Haemophilus Influenzae type b (v. 2/2024)
  
• Hepatitis A containing vaccines (v. 2/2024)
  
• Hepatitis B containing vaccines (v. 2/2024)
  
• Human Papillomavirus (v. 2/2024) 
  
• Influenza Inactivated Influenza Vaccines and Recombinant Influenza Vaccines 2023-2024 (v. 2/2024)
  
• Influenza Live Attenuated Influenza Vaccine 2023-2024 (v. 2/2024) 
• Japanese Encephalitis (v. 2/2024) 
  
• Measles, Mumps & Rubella containing vaccines (v. 2/2024) 
• Meningococcal containing vaccines (v. 2/2024) 
  
• Pneumococcal (v. 2/2024) 
  
• Polio (v. 2/2024) 
  
• Rabies (v. 2/2024)
• Respiratory Syncytial Virus (v. 2/2024)
  
• Tetanus, Diphtheria containing vaccines (v. 2/2024) 
  
• Typhoid (v. 2/2024) 
  
• Varicella containing vaccines (v. 2/2024) 
  
• Yellow Fever (v. 2/2024) 
• Zoster (v. 2/2024) 
  
• Division 041 related to Drug Outlet Pharmacy Requirements: Personnel, General, Non-Resident, Prescription, Laboratory, & Prescription Transfers *Effective 3/1/2024
  
• Division 080 related to Schedule II Prescriptions *Effective 12/19/2023
  
• Divisions 115/125 related to Pharmacist/COPT/PT Administration of Vaccines *Effective 3/1/2024
  
• Division 115 related to Pharmacist Supervision, Counseling, PIC: Qualifications & Limitations *Effective 3/1/2024
  
• Division 125 related to Pharmacy Technician Prohibited Practices *Effective 3/1/2024 
  

November 21, 2023 Rulemaking Hearing

• Divisions 019/025/041/139 related to Pharmacist/COPT/PT Administration of Vaccines
• Division 020 related to Vaccination Protocols - Protocol Compendium 
  
• Standard Protocol for All Vaccines: Cover Page & Assessment and Treatment Care Pathway (v. 10/2023)
  
• Standard Protocol for All Vaccines: Managing Adverse Reactions (v. 10/2023)
  
• Cholera (v. 10/2023)
  
• Coronavirus 19 (v. 10/2023)
  
• Haemophilus Influenzae type b (v. 10/2023)
  
• Hepatitis A containing vaccines (v. 10/2023)
  
• Hepatitis B containing vaccines (v. 10/2023)
  
• Human Papillomavirus (v. 10/2023) 
• Influenza Inactivated Influenza Vaccines and Recombinant Influenza Vaccines 2023-2024 (v. 10/2023)
  
• Influenza Live Attenuated Influenza Vaccine 2023-2024 (v. 10/2023) 
  
• Japanese Encephalitis (v. 10/2023) 
  
• Measles, Mumps & Rubella containing vaccines (v. 10/2023) 
  
• Meningococcal containing vaccines (v. 10/2023) 
  
• Pneumococcal (v. 10/2023) 
  
• Polio (v. 10/2023) 
  
• Rabies (v. 10/2023) 
  
• Respiratory Syncytial Virus (v. 10/2023)
  
• Tetanus, Diphtheria containing vaccines (v. 10/2023) 
  
• Typhoid (v. 10/2023) 
  
• Varicella containing vaccines (v. 10/2023) 
  
• Yellow Fever (v. 10/2023) 
  
• Zoster (v. 10/2023)
  
• Division 041 related to Drug Outlet Requirements 
  
• Division 080 related to Schedule II Prescriptions
• Divisions 115/125 related to Pharmacist/COPT/PT Administration of Vaccines
• Division 115 related to Pharmacist Applicability, Definitions, Supervision, Counseling, PIC:Qualifications & Limitations, and CPA & CDTM
• Division 125 related to Pharmacy Technician Prohibited Practices

October 2023

The board permanently adopted the following rules at the October 2023 Board meeting:

• Division 007 related to Compliance w/OHA COVID-19 rules - Repealed  *Effective 10/17/2023
  
• Divisions 019/041/043/044/139 related to Short-acting Opioid Antagonist  *Effective 10/17/2023 
• Division 045 related to USP <795> and USP <797> Standards adopted by Reference  *Effective 10/17/2023
• Division 115 related to Short-acting Opioid Antagonist  *Effective 3/1/2024
  
  

September 27, 2023 Rulemaking Hearing

• Division 007 related to Compliance w/OHA COVID-19 rules
  
• Divisions 019/041/043/044/139 related to Short-acting Opioid Antagonist 
  
• Division 045 related to USP <795> and USP <797> Standards Adopted by Reference 
• Division 115 related to Short-acting Opioid Antagonist
  
• Divisions 115/125 related to RPH Applicability, Definitions, Counseling; COPT/PT Prohibited Practices
  

August 2023

The board permanently adopted the following rules at the August 2023 Board meeting:

• Division 102 related to Board Administration  *Effective 3/1/2024
  
• Division 104 related to Universal Rules  *Effective 3/1/2024
• Division 115 related to Pharmacists  *Effective 3/1/2024 
• Division 120 related to Interns and Preceptors  *Effective 3/1/2024 
• Division 125 related to Pharmacy Technicians  *Effective 3/1/2024
  

July 26, 2023 Rulemaking Hearing

• Division 080 related to Schedule I - Xylazine
  
• Division 102 related to Board Administration
  
• Division 104 related to Universal Rules 
  
• Division 115 related to Pharmacists
  
• Division 120 related to Interns and Preceptors
  
• Division 125 related to Pharmacy Technicians 

• Divisions 041/043/183 related to Drug Compounding  *THE BOARD DOES NOT INTEND TO ADOPT THESE RULES IN AUGUST 2023 - SEEKING PUBLIC COMMENT ONLY

June 2023

The board permanently adopted the following rules at the June 2023 Board meeting:

• Divisions 006/041/043/045/080/139/141 related to Standards Adopted by Reference  *Effective 6/13/2023
  
• Divisions 019/020 related to Pharmacist Prescriptive Authority  *Effective 6/13/2023
  
• Continuation of Therapy including Emergency Refills of Insulin v. 6/2023
  
• Travel Medications v. 6/2023
  
• HIV Post-exposure Prophylaxis (PEP) v. 6/2023 
  
• HIV Pre-exposure Prophylaxis (PrEP) v. 6/2023 
• Contraception v. 6/2023 
• Divisions 019/041/043/045/080/139/141/143 related to Annual Self-Inspection Form Completion Date *Effective 8/1/2023 
  

May 23, 2023 Rulemaking Hearing

• Divisions 006/041/043/045/080/139/141 related to Standards Adopted by Reference
  
• Divisions 019/020 related to Pharmacist Prescriptive Authority
• COVID-19 Monoclonal Antibody & COVID-19 Antiviral Protocols *Repeal 
• Continuation of Therapy including Emergency Refills of Insulin v. 6/2023 
• Travel Medications v. 6/2023
  
• HIV Post-exposure Prophylaxis (PEP) v. 6/2023
  
• HIV Pre-exposure Prophylaxis (PrEP) v. 6/2023 
• Contraception v. 6/2023
  
• Divisions 019/041/043/045/080/139/141/143 related to Self-Inspection Form Completion Date
  

April 2023 Temporary Rule Noticed

• Division 045 related to USP <795> & USP <797> Adopted Standards by Reference  *Effective 5/5/2023

February 2023

The board permanently adopted the following rules as the February 2023 Board meeting:

• Divisions 019/041 related to Safe Pharmacy Practice Conditions: RPH Autonomy, Outlet Requirements *Effective 2/14/2023
  
• Division 110 related to Pharmacy Prescription Kiosk (PPK) Registration Fee *Effective 2/15/2023
  
• Division 019 related to Definitions *Effective 2/14/2023 
  

February 2023 Temporary Rule Noticed

• Division 020 - related to Protocols for COVID-19 Monoclonal Antibody & COVID-19 Antiviral *Effective 2/10/2023
  

January 26, 2023 Rulemaking Hearing

• Divisions 019/041 related to Safe Pharmacy Practice Conditions: RPH Autonomy, Outlet Requirements 
  
• Division 110 related to Pharmacy Prescription Kiosk (PPK) Registration Fee 
  
• Division 019 related to Definitions 
  

2023 Rulemaking Hearing Videos 

2022 Rulemaking

December 2022

The board permanently adopted the following rules at the December 2022 Board meeting: 

• Division 019 - related to 2022 HB 4034 Duties of a Pharmacist  *Effective 12/21/2022
• Division 139 - related to 2022 HB 4034 Prohibited Practices  *Effective 12/21/2022
• Division 019 - related to 2022 HB 4096 Out-of-state Volunteer Pharmacist  *Effective 12/21/2022
• Division 062 - related to Drug Distribution Agent  *Effective 12/21/2022
• Divisions 010/019/020 - related to Pharmacist Prescriptive Authority  *Effective 2/1/2023
  
• COVID-19 Antiviral (Paxlovid)  v. 12/2022  *Effective 2/1/2023
  
• Travel Medications  v. 12/2022  *Effective 2/1/2023 
• PEP  v. 12/2022  *Effective 2/1/2023
• PrEP v. 12/2022  *Effective 2/1/2023 
• Contraception v. 12/2022  *Effective 2/1/2023 
• Divisions 021/135 - related to Continuing Pharmacy Education  *Effective 7/1/2023 
• Divisions 019/141 - related to Pharmacy Prescription Kiosk (PPK)  *Effective 2/15/2023 
• Division 006 - related to Definitions  *Effective 12/21/2022 
• Division 041 - related to Prescription Labeling Expiration Date  *Effective 12/21/2022 
  

November 22, 2022 Rulemaking Hearing

• Division 019 - related to 2022 HB 4034 Duties of a Pharmacist 
• Division 139 - related to 2022 HB 4034 Prohibited Practices 
• Division 019 - related to 2022 HB 4096 Out-of-state Volunteer Pharmacist
  
• Division 062 - related to Drug Distribution Agent 
• Divisions 010/019/020 - related to Pharmacist Prescriptive Authority 
  
• COVID-19 Antiviral (Paxlovid)
  
• Travel Medications 
  
• PEP
  
• PrEP 
  
• Contraception 
  
• Divisions 021/135 - related to Continuing Pharmacy Education 
  
• Divisions 019/141 - related to Pharmacy Prescription Kiosk (PPK)
  
• Divisions 006/019/031 - related to Definitions
  
• Division 041 - related to Prescription Labeling Expiration Date
  
• Divisions 001/102 - related to Procedural & Universal Rules - *The board does not intend to adopt these rules in December 2022 - seeking public comment only 
  
• Divisions 025/125 - related to Pharmacy Technicians - *The board does not intend to adopt these rules in December 2022 - seeking public comment only 
  
• Divisions 019/020/031/041/115 - related to Pharmacists - *The board does not intend to adopt these rules in December 2022 - seeking public comment only
  

October 2022 Temporary Rules Noticed

• Division 020 - Pharmacist Prescriptive Authority - COVID-19 Antiviral  *Effective 10/17/2022
  
• COVID-19 Antiviral v.10/2022
• Division 041 - Prescription Labeling Expiration Date *Effective 10/17/2022
  

July 2022 Temporary Rules Noticed

• Division 019 - Duties of a Pharmacist - 2022 HB 4034 *Effective 7/1/2022
  
• Division 139 - RDSP Prohibited Practices - 2022 HB 4034 *Effective 7/1/2022
  

June 2022

The board permanently adopted the following rules at the June 2022 Board Meeting: 

• Divisions 006/041/043/045/080/139 - related to Standards Adopted by Reference & Definitions  *Effective 6/16/2022
  
• Divisions 019/025/041 - related to Certified Oregon Pharmacy Technician/Pharmacy Technician Final Verification *Effective 6/16/2022
  
• Divisions 019/041/139 - related to Interpreters  *Effective 9/1/2022
  
• Divisions 019/143 - related to Pharmacy Prescription Lockers *Effective 6/16/2022
  
• Division 020 - related to Pharmacist Prescriptive Authority - Tobacco Cessation & PrEP *Effective 6/16/2022
  
• Division 031 - related to Public Health Emergency Sunset *Effective 6/16/2022
  
• Division 041 - related to Telework *Effective 6/16/2022
  
• Divisions 041/139 - related to Permanent Pharmacy Closure Requirements *Effective 6/16/2022
  
• Division 080 - related to Pseudoephedrine/Ephedrine & Interns *Effective 6/16/2022
  
• Division 110 - related to Drug Outlet Categories *Effective 6/16/2022
  
• Division 139 - related to RDSP *Effective 6/16/2022
  
  

• Divisions 006/041/043/045/080/139 - related to Standards Adopted by Reference (and Definitions)
  
• Divisions 019/025/041 - related to Certified Oregon Pharmacy Technician/Pharmacy Technician Final Verification
  
• Divisions 019/041/139 - related to Interpreters 
  
• Divisions 019/143 - related to Pharmacy Prescription Lockers 
  
• Division 020 - related to Pharmacist Prescriptive Authority - Tobacco Cessation & PrEP
  
• Division 031 - related to Public Health Emergency Rules sunset 
  
• Division 041 - related to Telework 
  
• Divisions 041/139 - related to Permanent Pharmacy Closure Requirements 
  
• Division 080 - related to Pseudoephedrine/Ephedrine & Interns 
  
• Division 110 - related to Drug Outlet Categories 
  
• Division 139 - related to RDSP 
  

April 22, 2022 Temporary Rules Noticed

• Divisions 006/019/025/041 - related to Certified Oregon Pharmacy Technician/Pharmacy Technician Final Verification  *Effective 4/22/2022
  
• Division 041 - related to Telework *Effective 4/22/2022
  
• Division 080 - related to Pseudoephedrine/Ephedrine & Interns *Effective 4/22/2022
  
• Division 139 - related to RDSP *Effective 4/22/2022
  

The board permanently adopted the following rules at the April 2022 Board Meeting: 

• Divisions 006/041/139 - related to Definitions  *Effective 4/20/2022
  
• Division 020 - related to COVID-19 Antigen Self-Test Protocol *Effective 4/20/2022
  
• Divisions 020/041/065/139 related to Alarm, Audiovisual Communication, Entry & Surveillance Systems *Effective 4/20/2022
  
• Divisions 021/025/110 - related to Certified Oregon Pharmacy Technician & Pharmacy Technician Licensure *Effective 4/20/2022
  
• Division 041 - related to Disclosure of Patient Information *Effective 4/20/2022
  
• Division 041/139 - related to Accurate Pharmacy Hours & Temporary Pharmacy Closures *Effective 4/20/2022
  
• Division 080 - related to Schedule I Exceptions *Effective 4/20/2022
  
• Division 143 - related to Pharmacy Prescription Lockers (PPLs)  *Effective 4/20/2022
  

March 30, 2022 Temporary Rule Noticed

• Division 007- related to Emergency Registration Designation *Effective 3/30/2022 
  

March 29, 2022 Temporary Rule Noticed

• Division 007 - related to 91-day Extension after a Declared Emergency Ends *Effective 3/29/2022
  

March 29, 2022 Rulemaking Hearing

• Divisions 006/041/139 - related to Definitions
  
• Division 020 - related to COVID-19 Antigen Self-Test Protocol
  
• Divisions 020/041/065/139 - related to Alarm, Audiovisual Communication, Entry & Surveillance Systems
  
• Divisions 021/025/110 - related to Pharmacy Technician & Certified Oregon Pharmacy Technician Licensure
  
• Division 041- related to Disclosure of Patient Information
  
• Divisions 041/139 - related to Accurate Pharmacy Hours & Temporary Pharmacy Closures
  
• Divisions 041/139 - related to Drug Storage
  
• Division 080 - related to Schedule I Exceptions
  
• Division 143 - related to Pharmacy Prescription Lockers (PPLs) 
  

March 21, 2022

The board permanently adopted the following rules at the December 9, 2021 Board Meeting:

• Division 110 - related to Supervising Physician Dispensing Outlet fees  *Effective 3/31/2022
  

February 16, 2022 Temporary Rules Noticed

• Division 021/025/110 - related to Pharmacy Technician & Certified OR Pharmacy Technician Licensure *Effective 2/16/2022
  
• Division 041/139 - related to Permanent Closure Requirements for Pharmacies *Effective 2/16/2022
  

• Division 001/041 - related to Procedural Rules/Operations of Pharmacies
  
• Division 006/050 - related to Definitions 
• Division 007 - related to Public Health Emergency (Intern ratio) 
• Division 019/021/025/031 - related to Cultural Competency Continuing Education 
• Division 041 - related to Epinephrine 
• Division 041/043/044 - related to Limited English Proficiency (LEP) Informational insert 
  
• Division 041 - related to Drug Take Back 
  
• Division 020 - related to Pharmacist Prescriptive Authority - Protocols 
  
• Division 080 - related to Controlled Substances 
  
• Division 110 - related to Fees